Ferriprox (deferiprone)

pCPA File Number: 22202

Negotiation Status:

Concluded without agreement

Indication(s):

Transfusional iron overload due to sickle cell disease or other anemias

Sponsor/Manufacturer:

Chiesi Canada Corporation

CDA-AMC Project Number:

SR0741-000

pCPA Engagement Letter Issued:

2023-07-31

Negotiation Process Concluded:

2023-10-27